The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
WHO has sounded alarm over a sharp spike in HIV cases in the Philippines, Fiji and Papua New Guinea, urging urgent prevention ...
Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...
Morning Overview on MSN
Researchers make major progress toward curing HIV
On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...
More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...
"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently updated its clinical study titled A ...
ScienceAlert on MSN
HIV's Cunning Strategy For Hiding in Our Body Finally Revealed
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback